Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclophosphamide vs Mycophenolate Mofetil in Lupus Nephritis Induction
NCT03200002Phase 2Completed
- Sponsor
- Chitwan Medical College
- Start
- Jan 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of mycophenolate mofetil in lupus nephritis (LN) (2 arms), sponsored by Chitwan Medical College. Primary endpoint: Partial Remission at 6 months. Started Jan 2014; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT03200002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03200002.